High activity of acid sphingomyelinase in major depression

[1]  A. Sinclair,et al.  Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression , 2007, Lipids.

[2]  R. Shelton,et al.  Signal transduction abnormalities in melancholic depression. , 2005, The international journal of neuropsychopharmacology.

[3]  G. Besley,et al.  Enzyme activities and phospholipid storage patterns in brain and spleen samples from niemann-pick disease variants: a comparison of neuropathic and non-neuropathic forms , 1986, Journal of Inherited Metabolic Disease.

[4]  B. Ross,et al.  Delayed vasodilatory response to methylnicotinate in patients with unipolar depressive disorder. , 2004, Journal of affective disorders.

[5]  Yogesh K. Dwivedi,et al.  Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study. , 2004, Archives of general psychiatry.

[6]  K. Sandhoff,et al.  Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine , 2004, FEBS letters.

[7]  A. Bielawska,et al.  Ceramide Kinase Mediates Cytokine- and Calcium Ionophore-induced Arachidonic Acid Release* , 2003, Journal of Biological Chemistry.

[8]  R. Catalán,et al.  Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide. , 2003, European journal of biochemistry.

[9]  M. Topham,et al.  Ceramide-induced alterations in dopamine transporter function. , 2003, European journal of pharmacology.

[10]  P. Kinnunen,et al.  Observation of topical catalysis by sphingomyelinase coupled to microspheres. , 2002, Journal of the American Chemical Society.

[11]  P. Quinn,et al.  Ceramides increase the activity of the secretory phospholipase A2 and alter its fatty acid specificity. , 2002, The Biochemical journal.

[12]  R. Kolesnick,et al.  CD95 Signaling via Ceramide-rich Membrane Rafts* , 2001, The Journal of Biological Chemistry.

[13]  B. Johansen,et al.  Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Obeid,et al.  The Sphingomyelin Cycle and the Second Messenger Function of Ceramide " , 2001 .

[15]  C. Katona,et al.  Altered brain protein kinase C in depression: a post-mortem study , 2000, European Neuropsychopharmacology.

[16]  A. Nègre-Salvayre,et al.  Sphingomyelin metabolites in vascular cell signaling and atherogenesis. , 2000, Progress in lipid research.

[17]  C. Peters,et al.  Ceramide as an activator lipid of cathepsin D. , 2000, Advances in experimental medicine and biology.

[18]  C. Belka,et al.  Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Johns,et al.  Ceramide-induced vasorelaxation: An inhibitory action on protein kinase C. , 1999, General pharmacology.

[20]  K. Williams,et al.  Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[21]  A. Stoll,et al.  Omega-3 fatty acids--the missing link? , 1999, Archives of general psychiatry.

[22]  C. Nemeroff,et al.  The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.

[23]  A. Abe,et al.  Purification and Characterization of 1-O-Acylceramide Synthase, a Novel Phospholipase A2 with Transacylase Activity* , 1998, The Journal of Biological Chemistry.

[24]  F. Maxfield,et al.  Sphingomyelinase Treatment Induces ATP-independent Endocytosis , 1998, The Journal of cell biology.

[25]  M. Ito,et al.  Ceramide promotes calpain-mediated proteolysis of protein kinase C beta in murine polymorphonuclear leukocytes. , 1998, Biochemical and biophysical research communications.

[26]  T. Meyer,et al.  Acidic Sphingomyelinase Mediates Entry of N. gonorrhoeae into Nonphagocytic Cells , 1997, Cell.

[27]  F. Lang,et al.  Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Yogesh K. Dwivedi,et al.  Protein kinase C in the postmortem brain of teenage suicide victims , 1997, Neuroscience Letters.

[29]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[30]  R. Kolesnick,et al.  Kinase Suppressor of Ras Is Ceramide-Activated Protein Kinase , 1997, Cell.

[31]  D. Brenner,et al.  Ceramide Activates the Stress-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.

[32]  D. Fabbro,et al.  PKC zeta is a molecular switch in signal transduction of TNF‐alpha, bifunctionally regulated by ceramide and arachidonic acid. , 1995, The EMBO journal.

[33]  D. Green,et al.  FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. , 1995, Immunity.

[34]  J. Rotrosen,et al.  Elevated PLA2 activity in schizophrenics and other psychiatric patients , 1993, Biological Psychiatry.

[35]  Y. Nishizuka.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[36]  R. Dobrowsky,et al.  Ceramide stimulates a cytosolic protein phosphatase. , 1992, The Journal of biological chemistry.

[37]  J. Hauw,et al.  Modifications of sphingomyelin and phosphatidylcholine metabolism by tricyclic antidepressants and phenothiazines. , 1986, Life sciences.

[38]  R. Brady,et al.  Niemann-Pick disease experimental model: sphingomyelinase reduction induced by AY-9944. , 1977, Science.